Timo Vesikari, Joanne M Langley, Vlad Popovic, & Francisco Diaz-Mitoma. (2023). PreHevbrio: The first approved 3-antigen hepatitis B vaccine. Taylor & Francis Group.
Chicago Style (17th ed.) CitationTimo Vesikari, Joanne M Langley, Vlad Popovic, and Francisco Diaz-Mitoma. PreHevbrio: The First Approved 3-antigen Hepatitis B Vaccine. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationTimo Vesikari, et al. PreHevbrio: The First Approved 3-antigen Hepatitis B Vaccine. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.